tiprankstipranks
Apyx Medical Corporation (APYX)
NASDAQ:APYX
US Market
APYX
Apyx Medical
RESEARCH TOOLSreports

Apyx Medical (APYX) Ratios

Compare
205 Followers

Apyx Medical Ratios

APYX's free cash flow for Q4 2025 was $-0.10. For the 2025 fiscal year, APYX's free cash flow was decreased by $ and operating cash flow was
lt;0.01. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 5.00 5.00 5.26 5.52 3.63
Quick Ratio
 4.26 4.26 4.56 4.74 2.63
Cash Ratio
 2.71 2.71 2.96 3.43 0.86
Solvency Ratio
 -0.20 -0.20 -0.45 -0.34 -1.59
Operating Cash Flow Ratio
 -0.68 -0.68 -1.68 -0.41 -1.71
Short-Term Operating Cash Flow Coverage
 -18.69 -18.69 0.00 0.00 0.00
Net Current Asset Value
$ 6.46M$ 6.46M$ 5.93M$ 18.04M$ 28.99M
Leverage Ratios
Debt-to-Assets Ratio
 0.59 0.59 0.60 0.49 0.02
Debt-to-Equity Ratio
 2.71 2.71 2.73 1.44 0.02
Debt-to-Capital Ratio
 0.73 0.73 0.73 0.59 0.02
Long-Term Debt-to-Capital Ratio
 0.71 0.71 0.70 0.55 0.00
Financial Leverage Ratio
 4.60 4.60 4.56 2.97 1.38
Debt Service Coverage Ratio
 -0.85 -1.01 -2.89 -6.33 -1.49K
Interest Coverage Ratio
 -1.15 -1.15 -3.19 -6.96 -1.57K
Debt to Market Cap
 0.23 0.24 0.60 0.37 0.00
Interest Debt Per Share
 1.07 1.07 1.26 1.18 0.02
Net Debt to EBITDA
 -1.56 -1.31 -0.42 0.28 0.43
Profitability Margins
Gross Profit Margin
36.02%36.02%61.04%64.49%65.45%
EBIT Margin
-10.40%-12.20%-36.17%-35.92%-51.44%
EBITDA Margin
-9.22%-10.96%-34.93%-34.60%-49.44%
Operating Profit Margin
-12.20%-12.20%-39.18%-32.97%-52.94%
Pretax Profit Margin
-20.50%-20.50%-48.45%-40.65%-51.47%
Net Profit Margin
-21.22%-21.22%-48.78%-35.75%-52.09%
Continuous Operations Profit Margin
-21.01%-21.01%-48.98%-36.01%-52.30%
Net Income Per EBT
103.47%103.47%100.67%87.93%101.19%
EBT Per EBIT
168.09%168.09%123.68%123.31%97.24%
Return on Assets (ROA)
-16.77%-16.77%-36.18%-23.62%-44.78%
Return on Equity (ROE)
-117.54%-77.10%-165.12%-70.08%-61.69%
Return on Capital Employed (ROCE)
-11.69%-11.69%-34.82%-25.95%-59.02%
Return on Invested Capital (ROIC)
-11.60%-11.60%-34.59%-22.86%-58.64%
Return on Tangible Assets
-16.77%-16.77%-36.18%-23.62%-44.78%
Earnings Yield
-7.30%-7.60%-41.78%-20.63%-28.70%
Efficiency Ratios
Receivables Turnover
 3.15 3.15 3.11 3.73 2.44
Payables Turnover
 11.06 11.06 7.17 6.85 5.76
Inventory Turnover
 3.93 3.93 2.48 1.87 1.30
Fixed Asset Turnover
 7.99 7.99 7.14 7.33 5.87
Asset Turnover
 0.79 0.79 0.74 0.66 0.86
Working Capital Turnover Ratio
 1.25 1.14 0.93 1.18 1.13
Cash Conversion Cycle
 175.72 175.72 213.84 239.36 366.27
Days of Sales Outstanding
 115.87 115.87 117.46 97.77 149.62
Days of Inventory Outstanding
 92.86 92.86 147.31 194.83 279.99
Days of Payables Outstanding
 33.01 33.01 50.93 53.25 63.35
Operating Cycle
 208.74 208.74 264.77 292.60 429.61
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.19 -0.19 -0.51 -0.15 -0.59
Free Cash Flow Per Share
 -0.22 -0.22 -0.53 -0.17 -0.62
CapEx Per Share
 0.03 0.03 0.02 0.02 0.03
Free Cash Flow to Operating Cash Flow
 1.14 1.14 1.04 1.10 1.05
Dividend Paid and CapEx Coverage Ratio
 -7.18 -7.18 -25.00 -9.85 -20.08
Capital Expenditure Coverage Ratio
 -7.18 -7.18 -25.00 -9.85 -20.08
Operating Cash Flow Coverage Ratio
 -0.20 -0.20 -0.47 -0.14 -25.48
Operating Cash Flow to Sales Ratio
 -0.15 -0.15 -0.38 -0.10 -0.46
Free Cash Flow Yield
-5.99%-6.18%-33.42%-6.37%-26.36%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -13.69 -13.16 -2.39 -4.85 -3.48
Price-to-Sales (P/S) Ratio
 2.88 2.79 1.17 1.73 1.81
Price-to-Book (P/B) Ratio
 10.56 10.15 3.95 3.40 2.15
Price-to-Free Cash Flow (P/FCF) Ratio
 -16.70 -16.19 -2.99 -15.69 -3.79
Price-to-Operating Cash Flow Ratio
 -19.18 -18.44 -3.11 -17.28 -3.98
Price-to-Earnings Growth (PEG) Ratio
 -0.58 0.22 -0.11 0.25 -0.07
Price-to-Fair Value
 10.56 10.15 3.95 3.40 2.15
Enterprise Value Multiple
 -32.80 -26.80 -3.76 -4.72 -3.24
Enterprise Value
 159.86M 155.17M 63.18M 85.56M 71.37M
EV to EBITDA
 -32.80 -26.80 -3.76 -4.72 -3.24
EV to Sales
 3.03 2.94 1.31 1.63 1.60
EV to Free Cash Flow
 -17.54 -17.02 -3.37 -14.80 -3.35
EV to Operating Cash Flow
 -19.98 -19.39 -3.50 -16.30 -3.52
Tangible Book Value Per Share
 0.35 0.35 0.40 0.78 1.09
Shareholders’ Equity Per Share
 0.34 0.34 0.40 0.77 1.09
Tax and Other Ratios
Effective Tax Rate
 -0.02 -0.02 -0.01 0.11 -0.02
Revenue Per Share
 1.25 1.25 1.35 1.51 1.29
Net Income Per Share
 -0.27 -0.27 -0.66 -0.54 -0.67
Tax Burden
 1.03 1.03 1.01 0.88 1.01
Interest Burden
 1.97 1.68 1.34 1.13 1.00
Research & Development to Revenue
 0.06 0.06 0.11 0.09 0.10
SG&A to Revenue
 0.55 0.68 0.90 0.93 1.08
Stock-Based Compensation to Revenue
 0.03 0.04 0.08 0.10 0.15
Income Quality
 0.72 0.72 0.77 0.28 0.87
Currency in USD